what color is semaglutide red why some and some clear Is Semaglutide? Semaglutide, also known as Ozempic,

Bottom Line GLP-1 medications like Ozempic, Wegovy, Mounjaro, Zepbound, and others have transformed diabetes and weight-management care

Centralizing Context to Stop the Cycle of Rebound Most people manage transitions with calendars and memory, which works well until a rebound occurs and no one has a record to explain why

These medications include semaglutide (Ozempic, Wegovy), dulaglutide (Trulicity), liraglutide (Victoza, Saxenda), among others

Interestingly, new research published in the journal Nature Medicine evaluated the health outcomes of more than 2 million veterans with diabetes taking a GLP-1 and found that while the medications had positive effects on several health conditions, like heart disease and substance use disorders, they were negatively associated with some, including arthritis

Key Findings: Large human studies across multiple countries have not found increased thyroid cancer rates in GLP-1 users The FDA warning applies to medullary thyroid carcinoma (MTC)only 3-4% of all thyroid cancers The warning exists because rodents developed C-cell tumors, but humans and rodents differ biologically Some studies show associations, but these are explained by detection bias (more monitoring = finding pre-existing nodules) The Clayman Thyroid Center (2,000+ thyroid cancer patients/year) has not seen an MTC pattern linked to GLP-1 use (or for that matter any other thyroid malignancy) Clinical Recommendations: Patients with MTC history or MEN2 should not take GLP-1 receptor agonists Patients with common thyroid cancers (papillary, follicular, Hrthle cell) should not assume GLP-1 caused them or will have an effect upon them Decisions should be individualized, weighing metabolic benefits against theoretical concerns GLP-1 therapy does not require additional thyroid monitoring Quick Reference for Clinicians Understanding the Question What Medications Are We Discussing